XORTX Therapeutics, Inc. (XRTX)
0.845
0.00 (0.00%)
USD |
NASDAQ |
Nov 10, 16:00
0.845
0.00 (0.00%)
After-Hours: 16:29
XORTX Therapeutics Market Cap : 1.462M for Nov. 10, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 09, 2026 | 1.462M |
| November 06, 2026 | 1.575M |
| November 05, 2026 | 1.592M |
| November 04, 2026 | 1.713M |
| November 03, 2026 | 1.731M |
| November 02, 2026 | 1.748M |
| October 30, 2026 | 1.731M |
| October 29, 2026 | 1.782M |
| October 28, 2026 | 1.817M |
| October 27, 2026 | 1.904M |
| October 26, 2026 | 1.834M |
| October 23, 2026 | 1.592M |
| October 22, 2026 | 1.677M |
| October 21, 2026 | 1.610M |
| October 20, 2026 | 1.654M |
| October 19, 2026 | 1.748M |
| October 16, 2026 | 2.146M |
| October 15, 2026 | 2.458M |
| October 14, 2026 | 2.700M |
| October 13, 2026 | 2.907M |
| October 12, 2026 | 2.977M |
| October 09, 2026 | 2.440M |
| October 08, 2026 | 3.202M |
| October 07, 2026 | 3.020M |
| October 06, 2026 | 2.994M |
| Date | Value |
|---|---|
| October 05, 2026 | 2.942M |
| October 02, 2026 | 2.967M |
| October 01, 2026 | 2.994M |
| September 30, 2026 | 2.925M |
| September 29, 2026 | 2.942M |
| September 28, 2026 | 2.959M |
| September 25, 2026 | 2.925M |
| September 24, 2026 | 2.977M |
| September 23, 2026 | 2.942M |
| September 22, 2026 | 3.219M |
| September 21, 2026 | 3.375M |
| September 18, 2026 | 3.323M |
| September 17, 2026 | 2.873M |
| September 16, 2026 | 3.080M |
| September 15, 2026 | 3.254M |
| September 14, 2026 | 3.582M |
| September 11, 2026 | 4.032M |
| September 10, 2026 | 3.652M |
| September 09, 2026 | 3.735M |
| September 08, 2026 | 3.946M |
| September 04, 2026 | 3.998M |
| September 03, 2026 | 3.721M |
| September 02, 2026 | 4.292M |
| September 01, 2026 | 3.738M |
| August 31, 2026 | 4.015M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lexaria Bioscience Corp. | 7.767M |
| Mentari Therapeutics, Inc. | 67.13M |
| Target Group, Inc. (Canada) | 0.4936M |
| NervGen Pharma Corp. | 142.59M |
| Milestone Pharmaceuticals, Inc. | 85.43M |
Market Cap Related Metrics
| PEG Ratio | -0.0067 |
| Price to Book Value | 0.2657 |
| Price | 0.845 |
| Earnings Yield | -324.8% |
| PEGY Ratio | -0.0067 |